<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04700098</url>
  </required_header>
  <id_info>
    <org_study_id>F3513-R</org_study_id>
    <nct_id>NCT04700098</nct_id>
  </id_info>
  <brief_title>Internet-based Cognitive-behavioral Treatment for Insomnia in COPD Patients Undergoing Pulmonary Rehabilitation</brief_title>
  <official_title>Enhancing Pulmonary Rehabilitation in Veterans With Chronic Obstructive Pulmonary Disease Through Internet-based Cognitive-behavioral Treatment for Insomnia</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>VA Office of Research and Development</agency>
      <agency_class>U.S. Fed</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>VA Office of Research and Development</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study is a randomized controlled trial (RCT) to compare sleep and health-related&#xD;
      functioning in Veterans with chronic obstructive pulmonary disease (COPD) and insomnia&#xD;
      receiving an Internet-based behavioral treatment for insomnia during home-based pulmonary&#xD;
      rehabilitation (HBPR) versus those only receiving HBPR. Participants will undergo a sleep and&#xD;
      health assessment that will be performed prior to the beginning of HBPR and at the end of&#xD;
      HBPR and 6-months later. Participants will be randomly assigned to either Internet-based&#xD;
      behavioral treatment for insomnia plus HBPR or HBPR only.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Veterans with chronic obstructive pulmonary disease (COPD) are a vulnerable group for&#xD;
      developing insomnia. Pulmonary rehabilitation is a key component of COPD management, yet it&#xD;
      does not address sleep. Comorbid insomnia may interfere with Veterans achieving maximum&#xD;
      benefits from pulmonary rehabilitation. Implementing an insomnia-specific treatment in&#xD;
      Veterans with COPD undergoing pulmonary rehabilitation will likely lead to improved sleep&#xD;
      that could help improve and sustain the benefits gained from pulmonary rehabilitation.&#xD;
&#xD;
      This study is a randomized controlled trial (RCT) to compare sleep and health-related&#xD;
      functioning in Veterans with chronic obstructive pulmonary disease (COPD) and insomnia&#xD;
      receiving an Internet-based behavioral treatment for insomnia during home-based pulmonary&#xD;
      rehabilitation (HBPR) versus those only receiving HBPR. Veterans 40 years and older, who&#xD;
      received care from the VA Pittsburgh Healthcare System, and who have COPD and insomnia will&#xD;
      be recruited for this study. Participants will undergo a sleep and health assessment that&#xD;
      will be performed prior to the beginning of HBPR and at the end of HBPR and 6-months later.&#xD;
      Participants will be randomly assigned to either Internet-based behavioral treatment for&#xD;
      insomnia plus HBPR or HBPR only. Both the insomnia treatment and HBPR will be provided&#xD;
      remotely.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">November 30, 2021</start_date>
  <completion_date type="Anticipated">March 31, 2025</completion_date>
  <primary_completion_date type="Anticipated">September 2, 2024</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>Individuals will be assigned to either an internet-based behavioral treatment for insomnia plus home-based pulmonary rehabilitation or home-based pulmonary rehabilitation only simultaneously.</intervention_model_description>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Outcomes Assessor)</masking>
    <masking_description>Outcome assessor will be blinded to group assignment.</masking_description>
  </study_design_info>
  <primary_outcome>
    <measure>Insomnia Severity Index</measure>
    <time_frame>Baseline to post-pulmonary rehabilitation and 6-months post-pulmonary rehabilitation</time_frame>
    <description>The Insomnia Severity Index is a 7-item self-report questionnaire assessing nature, severity and impact of insomnia symptoms. The total score ranges from 0 to 28, with higher scores indicating worse insomnia severity.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>St. George's Respiratory Questionnaire</measure>
    <time_frame>6-months post-pulmonary rehabilitation</time_frame>
    <description>The SGRQ is a 50-item measure assessing disease-specific quality of life. The total SGRQ score, which reflects the overall impact of the disease on quality of life, ranges from 0 to 100, with higher scores indicating greater impairment.</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">125</enrollment>
  <condition>Chronic Obstructive Pulmonary Disease</condition>
  <condition>Insomnia</condition>
  <arm_group>
    <arm_group_label>Internet-based behavioral treatment for insomnia + HBPR</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Internet version of cognitive-behavioral treatment for insomnia plus home-based pulmonary rehabilitation</description>
  </arm_group>
  <arm_group>
    <arm_group_label>HBPR only</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Home-based pulmonary rehabilitation only</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Internet-based behavioral treatment for insomnia + HBPR</intervention_name>
    <description>Internet version of cognitive-behavioral treatment for insomnia plus home-based pulmonary rehabilitation</description>
    <arm_group_label>Internet-based behavioral treatment for insomnia + HBPR</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>HBPR only</intervention_name>
    <description>Home-based pulmonary rehabilitation only</description>
    <arm_group_label>HBPR only</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Age 40 years and older&#xD;
&#xD;
          -  Primary diagnosis of COPD defined by GOLD&#xD;
&#xD;
          -  Meets criteria for enrollment in pulmonary rehabilitation&#xD;
&#xD;
          -  Meets criteria for Insomnia Disorder&#xD;
&#xD;
          -  At least moderate insomnia severity based on Insomnia Severity Index score 10&#xD;
&#xD;
          -  Stable psychiatric and medical conditions&#xD;
&#xD;
          -  Must have telephone, email, and reliable Internet access via computer, smartphone, or&#xD;
             tablet&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Enrolled in pulmonary rehabilitation in the past 12 months&#xD;
&#xD;
          -  Untreated current major depression&#xD;
&#xD;
          -  Serious suicidal risk&#xD;
&#xD;
          -  Substance abuse disorder within past 3 months&#xD;
&#xD;
          -  History of bipolar or psychosis&#xD;
&#xD;
          -  Untreated restless legs syndrome, delayed sleep phase syndrome, irregular sleep&#xD;
             schedules&#xD;
&#xD;
          -  Very severe untreated obstructive sleep apnea&#xD;
&#xD;
          -  Severe excessive daytime sleepiness based on Epworth Sleepiness Scale score &gt; 16&#xD;
&#xD;
          -  Restrictive lung disease (FEV1/FVC 70 and FEV1 &lt; 80% predicted) or asthma&#xD;
&#xD;
          -  Plans to move during the following 9 months&#xD;
&#xD;
          -  Non-English speaking or sensory deficits&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>40 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Faith S Luyster, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>VA Pittsburgh Healthcare System University Drive Division, Pittsburgh, PA</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Faith S Luyster, PhD</last_name>
    <phone>(412) 360-2854</phone>
    <email>Faith.Luyster@va.gov</email>
  </overall_contact>
  <location>
    <facility>
      <name>VA Pittsburgh Healthcare System University Drive Division, Pittsburgh, PA</name>
      <address>
        <city>Pittsburgh</city>
        <state>Pennsylvania</state>
        <zip>15240</zip>
        <country>United States</country>
      </address>
    </facility>
    <contact>
      <last_name>Faith S Luyster, PhD</last_name>
      <phone>412-360-2854</phone>
      <email>Faith.Luyster@va.gov</email>
    </contact>
    <investigator>
      <last_name>Faith S Luyster, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>October 2021</verification_date>
  <study_first_submitted>January 4, 2021</study_first_submitted>
  <study_first_submitted_qc>January 5, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">January 7, 2021</study_first_posted>
  <last_update_submitted>October 15, 2021</last_update_submitted>
  <last_update_submitted_qc>October 15, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">October 22, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Chronic Obstructive Pulmonary Disease</keyword>
  <keyword>Insomnia</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Lung Diseases</mesh_term>
    <mesh_term>Lung Diseases, Obstructive</mesh_term>
    <mesh_term>Pulmonary Disease, Chronic Obstructive</mesh_term>
    <mesh_term>Sleep Initiation and Maintenance Disorders</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

